0001209191-23-021443.txt : 20230328
0001209191-23-021443.hdr.sgml : 20230328
20230328190904
ACCESSION NUMBER: 0001209191-23-021443
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230324
FILED AS OF DATE: 20230328
DATE AS OF CHANGE: 20230328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harris Todd
CENTRAL INDEX KEY: 0001711463
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 23771313
MAIL ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD
STREET 2: SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831476348
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-24
0
0001863127
Tyra Biosciences, Inc.
TYRA
0001711463
Harris Todd
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-03-24
4
M
0
170
2.25
A
1701446
D
Common Stock
2023-03-24
4
S
0
170
16.00
D
1701276
D
Common Stock
2023-03-27
4
M
0
2963
2.25
A
1704239
D
Common Stock
2023-03-27
4
S
0
2963
16.00
D
1701276
D
Common Stock
2023-03-28
4
M
0
2779
2.25
A
1704055
D
Common Stock
2023-03-28
4
S
0
2779
16.00
D
1701276
D
Stock Option (Right to Buy)
2.25
2023-03-24
4
M
0
170
0.00
D
2031-03-09
Common Stock
170
409606
D
Stock Option (Right to Buy)
2.25
2023-03-27
4
M
0
2963
0.00
D
2031-03-09
Common Stock
2963
406643
D
Stock Option (Right to Buy)
2.25
2023-03-28
4
M
0
2779
0.00
D
2031-03-09
Common Stock
2779
403864
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.
/s/ Ali D. Fawaz, Attorney-in-Fact
2023-03-28